Mednet Logo

How would you approach patients with high risk mucoepidermoid carcinoma (high grade) of the parotid gland for optimal adjuvant treatment?

5 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Answered on

Would be nice to know all the risk factors - margins, PNI, etc.

Due to high-risk features, adjuvant RT is appropriate and guideline-concordant

However, there is no strong supporting evidence to add adjuvant chemo as salivary gland cancers are typically not chemo-sensitive.

Published real-world data suc...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Johns Hopkins University School of Medicine
Answered on

The question of adjuvant therapy for this high-grade mucoepidermoid cancer is reasonable but I am in agreement with others that RT alone is the appropriate and evidence-based management in this case. Guidance from published literature consists mainly of retrospective case series that are heterogeneo...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

Postop RT. 60 Gy/30 fractions for R0, 66/33 for R1, 70/35 for R2 margins

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Michigan Medical School
Answered on

I agree. Data does not yet support radio sensitization for salivary gland tumors.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · The Oncology Institute of Hope and Innovation
Answered on

RT alone

Join for free or sign in to see the full answer